Sea Of Riches

What is Sea Of Riches?

The new Belmont is part of a major restructuring of the New York Racing Association’s operations, with Belmont replacing Aqueduct as the year-round home of downstate thoroughbred racing.

Aqueduct staged its final races June 28, ending a 132-year history at the Queens track. It remained open for simulcast wagering until September 7 before closing permanently.

The new Belmont is significantly different than the sprawling venue it replaced. The former 1.25 million-square-foot grandstand, which had become vastly oversized for the contemporary racing crowd, was demolished to make way for a much smaller, modern facility with a focus on hospitality and premium seating.

What is Sea Of Riches?

One of the proposals could be voted on next week by the city council and would directly affect the city’s clubs.

The meeting brought together 40 professionals from the clubs’ legal, communications and marketing departments, as well as executives from companies in the betting sector. Club officials are concerned about the financial impact of the measures, which could impact sponsorship contracts signed with betting companies.

One of the main concerns is Bill 560/2025, which is currently making its way through the council. The proposal prohibits advertising by betting companies at events in the city of São Paulo. This applies to events organised by public or private entities, whether for-profit or non-profit.

About Sea Of Riches

Lottomatica CEO Guglielmo Angelozzi described its merger with Cirsa as a “low-risk proposition”, during an investor call detailing the deal on Wednesday.

The Wednesday announcement promised the merger of the two listed gaming giants would create the second-largest listed global gaming and sports betting operator, with a pro forma adjusted EBITDA of approximately €2 billion ($2.3 billion).

Angelozzi, who is set to lead the combined company as CEO, told analysts on the post-announcement call that the deal was expected to be a “low-risk proposition” given the consistent growth demonstrated by both Lottomatica and Cirsa in recent years.